Open AccessIleitis Secondary to Oral Capecitabine Treatment?
Author(s) -
Rami Radwan,
Wanangwa C. Namelo,
Mark Robinson,
A. Brewster,
G. L. Williams
Publication year - 2012
Publication title -
case reports in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 20
eISSN - 1687-9627
pISSN - 1687-9635
DOI - 10.1155/2012/154981
Subject(s) - capecitabine , medicine , adjuvant , adjuvant therapy , colorectal cancer , cancer , oncology , intensive care medicine , gastroenterology
The efficacy of capecitabine as adjuvant therapy in colon cancer is well demonstrated and its lower toxicity rates when compared with 5-FU make it an increasingly more favourable option for patients. This case highlights the awareness of a potentially severe side effect related to the use of capecitabine, yet through the early identification of symptoms patients can be managed conservatively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom